Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

NARecruitingINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Leukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer
Interventions
PROCEDURE

buccal cells

custom myeloid gene panel (Myelo-Panel) to identify germline mutations predisposing to cancer development (Thermo Fisher Scientific)

PROCEDURE

bone marrow cells

"Bone marrow cells (optional, for comparison, only in a limited number of patients):~* morphological analysis~* immunophenotype~* cytogenetics/FISH~* analysis of CHIP by custom gene panel and high sensitivity NGS"

PROCEDURE

peripheral blood cells

analysis of CHIP by custom gene panel and high sensitivity NGS

PROCEDURE

bone marrow biopsy

"Bone marrow biopsy (optional, for comparison, only in a limited number of patients):~* histology~* immunohistochemistry"

Trial Locations (1)

20141

RECRUITING

Istituto Europeo di Oncologia, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER